Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein

Unique visitors: 465

Alfredo Juárez-Saldívar, Edgar E. Lara-Ramírez, Francisco Reyes-Espinosa, Alma D. Paz-González, Juan Carlos Villalobos-Rocha, Gildardo Rivera

Categorie

DOI

https://doi.org/10.3390/scipharm88040054